Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report-Reference-Cited by-同舟云学术

Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report

Published:2022-07-29 Issue:30 Volume:101 Page:e29635
ISSN:1536-5964
Container-title:Medicine
language:en
Short-container-title:

Author:

Li Jiyao,Liu Yiguo,Wu Guangtao,Wang Hongyan,Xu Xiaoyan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference32 articles.

1. Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis.;Karvouniaris;Infection and Drug Resistance,2022

2. Global dissemination of carbapenemase-producing klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods.;Lee;Front Microbiol,2016

3. A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii.;Fang;Medicine (Baltim),2017

4. 2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis.;Tunkel;Clin Infect Dis,2017

5. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.;De Bonis;Eur J Neurol,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Experience with Off-Label Intrathecal Administration of Selected Antibiotics in Adults: An Overview with Pharmacometric Considerations;Antibiotics;2023-08-05

2. Intrathecal tigecycline is a safe and effective treatment for central nervous system infections;encephalitis;2023-07-10

3. Treatment of Ventriculitis and Meningitis After Neurosurgery Caused by Carbapenem-Resistant Enterobacteriaceae (CRE): A Challenging Topic;Infection and Drug Resistance;2023-06

4. The Blood–Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults;Antibiotics;2022-12-19

5. Intrathecal or Intraventricular Tigecycline Therapy for Central Nervous System Infection Associated with Carbapenem-Resistant Klebsiella pneumoniae;Infection and Drug Resistance;2022-12